AstraZeneca Levant https://edenred.ae/, an affiliate of the multinational pharmaceutical and biotechnology company, has been recently recognized as one…
Category: Health care @IT
Loxo Oncology at Lilly Announces Updated Data from the Phase 1/2 BRUIN Clinical Trial for Pirtobrutinib at the American Society of Hematology Annual Meeting
Loxo Oncology at Lilly, a research and development group of Eli Lilly and Company (NYSE: LLY), today…
BenevolentAI achieves second major collaboration milestone with novel idiopathic pulmonary fibrosis target selected for AstraZeneca’s portfolio
Novel target for idiopathic pulmonary fibrosis was discovered using BenevolentAI’s AI-drug discovery platform and experimentally validated…
Novarad and PenRad partner to provide further diagnostic tracking functionality to healthcare providers
– Novarad, a leading provider of medical software, announced today that it has expanded its strategic partnership…
Viracta Therapeutics Presents Preclinical Vecabrutinib Data in Oral and Poster Presentations at ASH 2021
Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company targeting virus-associated malignancies, today announced the presentation of new…
Subtle Medical to Become the First Partner Siemens Healthineers Welcomes on Board Their New Open Recon¹ Interface
– Subtle Medical, a key provider of artificial intelligence (AI) solutions for medical imaging, and Siemens Healthineers,…
Azcom Technology Announces Production-Ready Radar-Based Solution for Child Presence Detection (CPD)
– Azcom Technology, a leading system engineering company, today announced the availability of its radar sensor-based software…
GoHealth to Present at the 4th Annual Evercore ISI HealthCONx Conference on Dec. 2, 2021
– GoHealth, Inc. (GoHealth) (NASDAQ: GOCO), a leading health insurance marketplace and Medicare-focused digital health company, announced that the…
Hoth Therapeutics Inks API and Drug Product Contracts with WuXi STA to Advance Manufacturing of HT-KIT Cancer Therapeutic
Hoth Therapeutics, Inc., (NASDAQ: HOTH) a patient focused biopharmaceutical company, announced today that it has entered into two…
Diamond Therapeutics Announces First Patient Dosed in Clinical Trial Evaluating Low-Dose Psilocybin
Diamond Therapeutics Inc. (“Diamond”), a drug development company focused on non-hallucinogenic, psychedelic-based therapies for use in…